KMT2D and neoplasm: The only known tumor that has been confirmed in pilomatricoma is caused by a somatic variant in CTNNB1. KS may predispose patients to pilomatricoma formation because CTNNB1 plays a role in the WNT pathway, which is regulated by KMT2D [162,163].